J.P. Morgan increases holdings in Asymchem Laboratories (06821) by approximately 227,400 shares at a price of around 58.84 Hong Kong dollars per share.

18:50 26/02/2025

On February 20th, JPMorgan Chase increased its holdings of Kellyeng (06821) by 227,356 shares, with a share price of 58.8364 Hong Kong dollars, totaling approximately 13.3768 million Hong Kong dollars.

According to the latest data from the Hong Kong Stock Exchange, on February 20, J.P. Morgan increased its holdings of Asymchem Laboratories (06821) by 227,356 shares, at a price of 58.8364 Hong Kong dollars per share, totaling approximately 13.3768 million Hong Kong dollars. After the increase, the latest number of shares held is approximately 1.4518 million shares, with a latest shareholding percentage of 5.26%.

Subsidiary of ApicHope Pharmaceutical Group (300723.SZ), the innovative drug APH03571 tablet has been accepted for clinical trial registration application.

Beijing Wantai Biological Pharmacy Enterprise (603392.SH): Recombinant trivalent rotavirus subunit vaccine (E. coli) approved for clinical trials.

Bank of America Securities: Maintains a "buy" rating on China Life Insurance (02628), expecting a 20 to 30% increase in new business value in the first quarter.

Subsidiary of ApicHope Pharmaceutical Group (300723.SZ), the innovative drug APH03571 tablet has been accepted for clinical trial registration application.

Beijing Wantai Biological Pharmacy Enterprise (603392.SH): Recombinant trivalent rotavirus subunit vaccine (E. coli) approved for clinical trials.

Bank of America Securities: Maintains a "buy" rating on China Life Insurance (02628), expecting a 20 to 30% increase in new business value in the first quarter.